Dr. Brian O’Rourke, President and CEO of the Canadian Agency for Drugs and Technologies in Health (CADTH), is pleased to announce that Dr. Maurice McGregor, MB, BCh, MD, FRCP(C), FRCP(Lond), FACC is the 2011 recipient of the Dr. Jill M. Sanders Award of Excellence in Health Technology assessment (HTA).
Affectionately known to his colleagues in health technology assessment as the “grandfather of HTA in Canada,” Dr. McGregor is one of the preeminent figures in this important field of health policy analysis, and has consistently demonstrated an unrelenting passion for improving the recognition, production and utilization of HTA in Canada.
As the founding President of Quebec’s HTA Agency, the Conseil d’évaluation des technologies de la santé du Québec (1988 to 1994), and a founding Board member of the Canadian Coordinating Office for Health Technology Assessment, Dr. McGregor was instrumental in building the initial framework for the production and use of HTA in Canada. As the Chair of the HTA Unit at the McGill University Health Centre (MUHC), he helped extend the use of HTA to hospitals and regional health authorities. As the author of more than 180 articles and as Chair and Editor of Canada’s Guidelines for the Management of Breast Cancer (1994-98), he championed the use of evidence in clinical practice. As a professor at McGill University, he was a mentor to new generations of HTA producers and users.
Dr. McGregor is currently an Honorary Physician and Chair of the Technology Assessment Unit of the McGill University Health Centre and Professor Emeritus of McGill University. In December 2010, he was appointed Officer of the Order of Canada for having pioneered and championed the field of health technology assessment in Canada, and for his leadership in medical education and cardiology. The Dr. Jill M. Sanders Award will be presented to Dr. McGregor during an Awards Luncheon at the 2011 CADTH Symposium in Vancouver, BC. The Luncheon will be held on Tuesday, April 5, 2011 from 11:45 a.m. – 1:15 p.m.